Why the study?
Does Fibrinopeptide A (FPA) monitoring predict coronary reocclusion in patients with acute myocardial infarction treated with rt-PA?
Population
34 consecutive patients with acute myocardial infarction
Design
Cohort
Follow-up
12.5 +/- 6.1 days for angiography
Authors
Loading...
Persistently high postlytic FPA may signal reocclusion risk after rt-PA; hypothesis-generating and requires prospective validation before clinical use.
Does Fibrinopeptide A (FPA) monitoring predict coronary reocclusion in patients with acute myocardial infarction treated with rt-PA?
Persistently high or increasing Fibrinopeptide A levels after rt-PA therapy for acute myocardial infarction may indicate ongoing fibrin generation and predict coronary reocclusion.
Rapold et al. (1989) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: